LivaNova (LIVN) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
11 Jun, 2026Opening remarks and agenda
Meeting conducted virtually to maximize shareholder participation and ensure accessibility.
Quorum requirements confirmed as met, with formal opening declared just after 3:00 P.M. in London.
Agenda and rules of conduct made available on the meeting screen.
Board and executive committee updates
Introduction of all board members and company officers, including recognition of Sharon O'Kane for her service as she is not standing for re-election.
Overview of voting outcomes
Approximately 51 million ordinary shares, representing 93% of voting rights, participated.
Ten resolutions presented, including director elections, executive compensation, auditor appointments, share allotment, and share repurchase authorizations.
Final voting results to be published on the company website and reported to the SEC.
Latest events from LivaNova
- Growth is accelerating via core reinvestment, innovation, and disciplined margin management.LIVN
Goldman Sachs 47th Annual Global Healthcare Conference 20268 Jul 2026 - Double-digit 2025 growth and margin gains set stage for 6–7% revenue growth in 2026.LIVN
Q4 20258 Jul 2026 - Growth in core businesses and promising OSA trial results offset RECOVER trial challenges.LIVN
Goldman Sachs 45th Annual Global Healthcare Conference8 Jul 2026 - Portfolio transformation targets growth in epilepsy, cardiopulmonary, and sleep apnea with digital innovation.LIVN
Wolfe Research Healthcare Conference 20258 Jul 2026 - OSA and epilepsy growth accelerate on clinical, reimbursement, and innovation milestones.LIVN
44th Annual J.P. Morgan Healthcare Conference8 Jul 2026 - Q2 revenue and adjusted EPS rose, with raised guidance and strong Cardiopulmonary growth.LIVN
Q2 20248 Jul 2026 - Double-digit organic growth, margin expansion, and innovation milestones set up strong 2025 outlook.LIVN
Q4 20248 Jul 2026 - Raised 2026 revenue and EPS guidance after double-digit Q1 growth and key regulatory wins.LIVN
Q1 20266 May 2026 - Shareholders will vote on directors, executive pay, auditors, share authority, and ESG initiatives.LIVN
Proxy filing29 Apr 2026